Medtech Big 100: Just missed the list
No. 104: Outset Medical
Revenue: $115,375,000
R&D expenditures: $48,855,000
Employees: 728
CEO: Leslie Trigg
HQ: San Jose, California
www.outsetmedical.com
Outset Medical develops hemodialysis technology to reduce the cost and complexity of dialysis. The company’s Tablo hemodialysis system is FDA-cleared for use in the hospital and the home. It can be used across the continuum of care to allow for dialysis to be delivered at anytime, anywhere and by anyone. It has remote patient monitoring and two-way communication with the cloud via the company’s TabloHub to transmit treatment data to the provider and to a unique remote diagnostics platform that powers service and support.